<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Serum samples from 57 Turkish patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's syndrome (BS) were analysed for C-reactive protein, histidine, total sulphydryl concentration and <z:chebi fb="0" ids="24190">gamma glutamyl</z:chebi> transpeptidase </plain></SENT>
<SENT sid="1" pm="."><plain>Clinical subgroups did not exhibit biochemical differences, including BS with and without <z:hpo ids='HP_0001369'>arthritis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>When compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls and with patients with active <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (RA), those with BS were shown to be biochemically abnormal in a manner quantitatively similar to RA, but to a lesser degree </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="24190">Gamma-glutamyl</z:chebi> transpeptidase concentrations were found to be <z:mpath ids='MPATH_458'>normal</z:mpath> in BS </plain></SENT>
</text></document>